Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/47345
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSanjaya Anandram Bhaten_US
dc.date.accessioned2011-12-27T07:16:07Z
dc.date.available2011-12-27T07:16:07Z
dc.date.copyright2004en_US
dc.date.issued2004
dc.identifier.urihttp://hdl.handle.net/10356/47345
dc.description178 p.en_US
dc.description.abstractNew product development in biomedical device industry is a very complex process due to the presence of stringent regulatory requirements (e.g. FDA), intellectual property battles and complex nature of market where highly influential intermediaries (medical doctors) not only make product selection for end users (patients) but also contribute to product development. As a result, only a few technological innovations succeed in reaching the market and fewer become commercially successful. Hence many medical device companies are observed to be actively seeking new sources innovation, which includes universities and users. This notion is bolstered in Singapore due to government's emphasis on biomedical research and increasing attempts to transfer university innovations to the industry.en_US
dc.rightsNanyang Technological Universityen_US
dc.subjectDRNTU::Business::Marketing::Product managementen_US
dc.titleJohnson & Johnson medical, Singapore : new product development through university technology transferen_US
dc.typeThesisen_US
dc.contributor.supervisorTang Hung Keien_US
dc.contributor.schoolNanyang Business Schoolen_US
dc.description.degreeMaster of Business Administrationen_US
item.grantfulltextrestricted-
item.fulltextWith Fulltext-
Appears in Collections:NBS Theses
Files in This Item:
File Description SizeFormat 
NBS_THESES_49.pdf
  Restricted Access
15.28 MBAdobe PDFView/Open

Page view(s) 20

734
Updated on Apr 28, 2025

Download(s)

9
Updated on Apr 28, 2025

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.